Xintōpica® 1.5 mg

Xintōpica® 1.5 mg

Antipruritic. Control of Atopic Dermatitis and Pruritus Associated with Allergic Dermatitis in Dogs.

Canines Soft Chews

Each 1000 mg chewable tablet contains: Oclacitinib (as Oclacitinib maleate) 1.5 mg, Excipients and flavorings q.s.ad 1 tablet.

Treatment of pruritus associated with allergic dermatitis in dogs, including flea allergies. Treatment of the clinical manifestations of atopic dermatitis in dogs. Temporary relief of pruritus  associated with sarcoptic mange.

Xintōpica® It is administered orally, at 0.4 - 0.6 mg/kg PO every 12 hours for up to 14 days, then 0.4 - 0.6 mg/kg every 24 hours as maintenance therapy.

SENASA Registry: F.115.031.N.00012.

Petmedica® is a division of Agrovet Market S.A.
This content is an informational reference and should not be considered as recommendation of use.

You may also be interested

19_98d807ea41c7515796b0934dd0ebe4e8.png
Amoxi-Tabs C®-250
Broad-spectrum antibiotic with bacterial resistance...
Antibiotics
390_d9a3e3222d64142e0649d495f5cb3fcf.png
Biosporine® 3
Triple Topical Broad Spectrum Antibiotic...
Antibiotics
352_c73c4d242d1210b9160d972ca457d79f.png
Cefoxi-Tabs® C
Last Generation Cephalosporin Antibiotic with...
Antibiotics